confirmed (McConkey, Fraser, and Bligh, 1965) . Furthermore, the skin of many patients is friable, resists shear stresses poorly, and may produce problems in wound healing. Previous studies on skin collagen in these patients have been confined to measurements of soluble or total content. However, although total collagen is reduced, particularly in patients receiving corticosteroids, measurements on the small soluble fraction (<5 per cent) have been inconclusive. The major fraction of skin collagen is polymeric collagen, and having developed methods of measuring quantities and stability of this collagen in biopsies (85 sq. mm.) of human skin, we have applied them to patients with rheumatoid arthritis (Francis and Macmillan, 1971) .
So far 19 biopsies have been performed, including repeat biopsies in two patients after 6 months' penicillamine therapy. Compared with matched normal controls, a modest reduction in total skin collagen, particularly in patients on prolonged corticosteroid therapy has been confirmed. However, the stability ofthe polymeric collagen was not clearly altered by these drugs but was reduced in patients with active disease. With penicillamine, skin thickness and total collagen content were dramatically reduced. In addition, there was a reduction in collagen stability. In patients on corticosteroids there was an increased proportion of soluble collagen.
It will be suggested that important changes in collagen metabolism occur in these patients which may influence skin strength, integrity and wound healing (and perhaps renew interest in the 'collagen diseases'). Discussion DR. B. MCCONKEY (Birmingham) There is a distinction which is in danger of being lost between two different kinds of skin abnormality seen in patients with rheumatoid disease and sometimes in the elderly. One is the abnormality in which you get senile or steroid purpura and fragile skin, and the other is what we have called 'transparent skin' (McConkey, Fraser, Bligh, and Whiteley, 1963) . Although patients with one tend also to have the other, I think the conditions are quite distinct and ought to be considered separately in studies of this sort. DR. R. GRAHAME (London) One of your earlier slides suggested that there was no difference in total skin collagen in normal subjects and in patients who have not had steroids. This is different to the results of Shuster, Raffle, and Bottoms (1967 It is often supposed that surgical wounds are more liable to become infected or to heal poorly in patients with rheumatoid arthritis compared with controls and that corticosteroid therapy is likely to exaggerate these tendencies. There is considerable indirect evidence to support these concepts and this will be presented.
Since orthopaedic surgical procedures are being increasingly used in the management ofrheumatoid arthritis, it seemed valuable to compare postoperative wound healing in these patients and control subjects.
In a retrospective study covering a period of 20 months, 100 patients with rheumatoid arthritis undergoing a variety of orthopaedic operations were matched with others undergoing operation for conditions other than rheumatoid arthritis and other inflammatoryjoint diseases. Ofthe patients with rheumatoid arthritis, 49 were receiving corticosteroids. Details of wound infection, wound haematoma formation, and wound healing were obtained from the medical and nursing records.
There were 13 wound infections, all superficial, in the patients with rheumatoid arthritis and eight superficial infections in the control group (P > 0-10). Eleven of the 13 patients with rheumatoid arthritis were receiving corticosteroids (P < 0 02). Eight of 26 rheumatoid patients undergoing Macintosh knee arthroplasty had wound infections. There were seven wound haematomas in the rheumatoid patients and fivein the control group (P > 0I10), although in three of the latter anticoagulant therapy was a major cause. Anticoagulants were not given to patients with rheumatoid arthritis. Altogether 31 wounds failed to heal by primary intention in the rheumatoid group and 16 in the control group (P < 0 02). There was no difference in the mean number of days ±1 S.D. to complete wound healing between the rheumatoid patients (16-6 ± 7-5) and the controls (15-2 ± 7 9). There was no correlation between the days to healing and activity of arthritis, duration of disease, or positive serological test for rheumatoid factor. However, patients receiving corticosteroids for more than 3 years took longer to heal their wounds (20-3 ± 11-0 days) compared to those receiving these drugs for 3 years or less (15-2 + 4-9 days; P < 0 05). There was no correlation between haemoglobin concentrations and wound healing in either patient group.
It will be suggested that, although there are several theoretical and a number of practical reasons inherent in a study of this type which can never be truly comparative, which would lead one to expect problems with wound healing in patients with arthritis, only minor differences between the patient groups were demonstrated. The results may influence the surgical management of these patients. (Rhoads and Kasinskas, 1942) . The severity and activity of the disease is also an important factor and it is closely bound up with related parameters such as haemoglobin concentration and rheumatoid factor titre. All these factors operate adversely in patients with the more severe kind of connective tissue disease and particularly when the disease is active. Such patients with active disease are often anaemic or have disturbed serum proteins with elevated globulin and low albumin or are underweight; they undoubtedly carry a high incidence of wound infection. Treatment with corticosteroids influences wound healing adversely only if it is given in a dose high enough to produce obvious hypercorticism. When the dosage is optimal, there is an improvement in the general condition of the patient and a favourable change in the anaemia and serum protein concentrations with hypercorticism; there will then result an improved wound healing rate and a reduced incidence of infection. Comparable patients not treated with steroids will heal less well. On the other hand, if the dose of steroids is enough to produce the clinical signs of Cushing's syndrome, then there will be a corresponding increase in the rate of wound dehiscence and infection. DR. MOWAT With respect, sir, these are impressions that people have. They are largely undocumented impressions and we set out to investigate them. Our results suggest the very opposite ofwhat many people think; haemoglobin values had nothing to do with wound healing and serum proteins seemed likely to produce little difference. We looked at the erythrocyte sedimentation rate and the activity of the disease and found no correlation. DR. A. J. POPERT I was going to point out that yours is not the only paper which has been written on this subject. Peter Davis and I published a paper on this in 1958 (Popert and Davis, 1958) and I presented a paper on some eight cases to the Heberden Society in 1963 (Popert, 1963) . There is a vast mass of other data (cited by Popert, 1962) on this subject, which you may not have fully culled.
DR. MOWAT I should be most interested to have those references. Most of the work is on animals and I was not aware that you had published in this field. Our results clearly disagree. PROF. J. J. R. DUTHIE (Edinburgh) I should like to point out that the level of haemoglobin will not be significant until it has fallen to around about the 70 per cent mark. Your mean was 12-8g., which is 84 per cent so you did not have very anaemic patients for a start. The ESR was in the thirties, so that you did not have many active patients. 
